CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- 4 Shares withheld for taxes VP of Finance gave up 34 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and EVP gave up 171 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 277 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Finance gave up 34 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and EVP gave up 171 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 284 shares (to pay taxes)
- 10-K Report Annual Report
- 4 Grant or award CFO and EVP acquired 10,000 shares (grant or award)
- 4 Grant or award VP of Finance acquired 7,000 shares (grant or award)
- 4 Grant or award CEO acquired 30,000 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes CFO and EVP gave up 171 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Finance gave up 35 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 285 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes CFO and EVP gave up 171 shares (to pay taxes)
Page 30 of 77 · 1,525 filings